Euro-Sante :: Euro-Health

Archives for English

Sweden is home to the Karolinska Institute, one of the most effective bio-medical institutions in the EU. The worst thing the EU could do would be to copy Sweden; they are exemplary. What should be left behind at the end of December is a commitment by member states to unleash the creativity in their research… » read more

Posted by EuroSante

The Swedish presidency has identified a number of health priorities. I’d like to reflect on the following: 1. patient mobility directive, 2. e-health cooperation, and 3. flu. Patient mobility adds cross-border health risk as people with diseases move around. Zoonoses, diseases caught from animals (and it is worth remembering that animals catch diseases from humans,… » read more

Posted by EuroSante

Considerable public funding goes into research. To the dismay, though, of many, European countries in the main are very poor at commercialising this research, and thus return of this public investment is often zero euros. Reasons lie in at least two places: EU member states (outside of the ‘anglo’ tradition) tend to ‘own’ their own… » read more

Posted by EuroSante

The British have raised the issue that cross-border healthcare will only benefit the few: All EU citizens, not just the wealthy or well informed, must be able to benefit Baroness Howarth of Breckland, of the House of Lords’ EU Committee Is this fear or concern justified? The whole point of enabling European citizens to have… » read more

Posted by EuroSante

Greedy governments stifle innovation by reserving all the intellectual property of publicly funded research for their own use. The problem is that governments are not very good at knowing what to do next, and invariably tie up valuable innovation in bureaucratic process, without adding any social value at all. The Eurocrats like US comparisons, so… » read more

Posted by EuroSante

The Innovative Medicines Initiative seeks to put right the chaotic treatment of pharmaceutical innovation by EU member states, and will likely fail. The goose that lays golden eggs of medical innovation is cooked to death by member state medicines policies. Increasing the speed of product development will come to a grinding halt as member states… » read more

Posted by EuroSante